TeachMeFinance.com - explain CP-358,774
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called epidermal growth factor receptor tyrosine kinase inhibitors. Also called erlotinib.
About the author
Copyright © 2005 by Mark McCracken, All Rights Reserved. TeachMeFinance.com is an informational website, and should not be used as a substitute for professional medical, legal or financial advice. Information presented at TeachMeFinance.com is provided on an "AS-IS" basis. Source of definition: The National Cancer Institute. Please read the disclaimer for details.